World Library  
Flag as Inappropriate
Email this Article

1-Methyl-5-methoxy-diisopropyltryptamine

Article Id: WHEBN0014807549
Reproduction Date:

Title: 1-Methyl-5-methoxy-diisopropyltryptamine  
Author: World Heritage Encyclopedia
Language: English
Subject: 4-Acetoxy-MiPT, 2,5-Dimethoxy-4-propylamphetamine, Ditran, HZ-2, Lysergic acid 3-pentyl amide
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

1-Methyl-5-methoxy-diisopropyltryptamine

1-Methyl-5-methoxy-diisopropyltryptamine
Systematic (IUPAC) name
1-Methyl-5-methoxy-N,N-diisopropyltryptamine
Clinical data
Legal status
  • UK: Unscheduled
  • US: Unscheduled
Routes oral, insufflated, smoked, IV
Identifiers
ATC code ?
Chemical data
Formula C18H28N2O 
Mol. mass 288.4
 YesY   

1-Methyl-5-methoxy-diisopropyltryptamine (also known as 1-methyl-5-methoxy-N,N-diisopropyltryptamine, and 1-Me-5-MeO-DiPT) is a tryptamine that is used recreationally as a psychedelic. 1-methyl-5-MeO-DiPT is orally active, and dosages between 20-40 mg are commonly reported. Many users note that the an unpleasant body load that accompanies higher dosages of 5-MeO-DiPT is often absent when taking 1-methyl-5-MeO-DiPT. 1-methyl-5-MeO-DiPT is also taken by insufflation, or sometimes it is smoked or injected. Some users also report sound distortion, also noted with the related drug, DiPT. 1-methyl-5-MeO-DiPT is the 1-methyl homologue of 5-MeO-DiPT with a methyl group on the 1 position - the nitrogen in the tryptamine skeleton.

Effects

Positive

Neutral

  • Feelings of body & muscle energy, buzzing
  • Auditory distortions, pitch shifts
  • Visual distortions, open and closed-eye patterning, movement trails, shifting colors
  • Physical and mental stimulation

Negative

  • Possible stomach discomfort, gas and vomiting
  • Possible minor jaw-clenching
  • Possible Diarrhea
  • Anxious stimulation
  • Muscle tension / discomfort
  • Possible insomnia for 4-12 hours after peak
  • Possible male impotence for duration of drug's effects during higher doses

Legality

1-Methyl-5-methyoxydiisopropyltryptamine is not specifically scheduled in the US or any EU country. However, it might fall under the remit of various analogue acts.

See also

References

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.